Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Having a good listener is associated with greater cognitive resilience

Supportive social interactions in adulthood are important for your ability to stave off cognitive decline despite brain aging or neuropathological changes such as those present in Alzheimer's disease, a new study finds.

16 Aug 2021

Study illuminates the link between cholesterol and Alzheimer's-associated toxic protein clumps

A team co-led by scientists at Scripps Research has used advanced imaging methods to reveal how the production of the Alzheimer's-associated protein amyloid beta (Aβ) in the brain is tightly regulated by cholesterol.

13 Aug 2021

Metabolism peaks much earlier and starts to decline later than you might think

Most of us remember a time when we could eat anything we wanted and not gain weight. But a new study suggests your metabolism, the rate at which you burn calories, actually peaks much earlier and starts its inevitable decline later than you might think.

12 Aug 2021

Scientists find clues to how a specific synapse type regulates anxiety-like behavior

The mechanisms behind the organization of neuronal synapses remain unclear owing to the sheer number of genes, proteins, and neuron types involved.

12 Aug 2021

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

More than half of the survivors of West Nile virus brain infections are left with memory disorders that make everyday tasks such as remembering the route from home to work challenging.

12 Aug 2021

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Researchers at the Case Western Reserve University School of Medicine, with colleagues from the John P. Hussman Institute for Human Genomics at the University of Miami, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, at Columbia University, and Wake Forest University School of Medicine will study the genomics of Alzheimer's disease (AD) in people with African heritage throughout the United States.

12 Aug 2021

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

A new study from the University of Eastern Finland suggests that skin fibroblasts from frontotemporal dementia patients may be useful in investigating underlying disease mechanisms as well as in biomarker and drug research.

12 Aug 2021

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Improving the impact of high dementia rates on Indigenous Australians and communities is the focus of a University of Queensland-led telehealth project with a global track record of success.

11 Aug 2021

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Beige is considered a calming paint color, and scientists have new evidence that beige fat has a similar impact on the brain, bringing down the inflammation associated with the more common white fat and providing protection from dementia.

10 Aug 2021

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Previous studies of suicide in the 1700s have focussed on societal attitudes rather than the experiences of people who took their own lives. These suicides have largely been described as 'medicalised' acts driven by lunacy.

10 Aug 2021

Study explores ‘brain fog’ following COVID-19

A recent survey conducted in the United Kingdom revealed that approximately one in every five experiences prolonged coronavirus disease 2019 (COVID-19) symptoms five weeks post-infection. Also, one in seven people reported persistent symptoms even after twelve weeks.

10 Aug 2021

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Ultra-sensitive Simoa® HD-X technology powers new findings that detect rapid reduction of plasma P-tau217 from donanemab, Lilly’s investigational antibody therapy for Alzheimer's disease at 12 weeks

From Quanterix 9 Aug 2021

Light therapy may speed up the healing of burns by activating growth protein

Light therapy may accelerate the healing of burns, according to a University at Buffalo-led study.

6 Aug 2021

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

The recent US Food and Drug Administration (FDA) approval of aducanumab – which has the potential to treat Alzheimer's disease – may provide a proof of concept that can be rapidly improved upon, writes Dennis Selkoe in this Perspective.

6 Aug 2021

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

As covid-19 resurges across the country, driven by the highly infectious delta variant, experts are extending our understanding of the pandemic's toll on older adults — the age group hit hardest by the pandemic.

6 Aug 2021

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.

6 Aug 2021

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Having a good listener is associated with greater cognitive resilience

Study illuminates the link between cholesterol and Alzheimer's-associated toxic protein clumps

Metabolism peaks much earlier and starts to decline later than you might think

Scientists find clues to how a specific synapse type regulates anxiety-like behavior

Researcher receives $8.7 million to investigate the link between viral infections and memory disorders

Researchers to study the genomics of Alzheimer's disease in people with African heritage

Skin cells could provide better understanding of molecular mechanisms of frontotemporal dementia

UQ-led telehealth project focuses on easing dementia’s burden on Indigenous Australians

Beige fat cells mediate subcutaneous fat's brain protection from dementia

Study uncovers startling evidence from coroners' inquests into suicides of older people in the 1700s

Study explores ‘brain fog’ following COVID-19

Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021

Light therapy may speed up the healing of burns by activating growth protein

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

Clarity on covid count: Pandemic’s toll on seniors extended well beyond nursing homes

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Study reveals structural differences and unique polymorphs in amyloid-β fibrils

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

Restoring cholesterol levels could be a new therapeutic approach for diseases linked to TDP-43 protein

Key protein linked to both physical fitness in youth and diseases of old age

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Aneuro: An Overview of Neuroscience Research eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in